These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22566771)

  • 21. Off-Label Use of Clozapine in Children and Adolescents-A Literature Review.
    Rachamallu V; Elberson BW; Vutam E; Aligeti M
    Am J Ther; 2019; 26(3):e406-e416. PubMed ID: 31082865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor.
    Hjerde E; Dahl SG; Sylte I
    Eur J Med Chem; 2005 Feb; 40(2):185-94. PubMed ID: 15694653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic.
    Molander L; Borgström L
    Psychopharmacology (Berl); 1983; 79(2-3):111-4. PubMed ID: 6133299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
    Matsubara S; Meltzer HY
    Life Sci; 1989; 45(15):1397-406. PubMed ID: 2571912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sedative effects and prolactin response to single oral doses of melperone.
    Molander L; Borgström L
    Psychopharmacology (Berl); 1983; 79(2-3):142-7. PubMed ID: 6133301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone versus clozapine in treatment-resistant schizophrenia: a randomized pilot study.
    Wahlbeck K; Cheine M; Tuisku K; Ahokas A; Joffe G; Rimón R
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):911-22. PubMed ID: 11041534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.
    Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA
    Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical issues with amisulpride in the management of patients with schizophrenia.
    Pani L; Villagrán JM; Kontaxakis VP; Alptekin K
    Clin Drug Investig; 2008; 28(8):465-77. PubMed ID: 18598092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
    Masuda T; Misawa F; Takase M; Kane JM; Correll CU
    JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.
    Pöldinger WJ
    Neuropsychobiology; 1984; 11(3):181-6. PubMed ID: 6147789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.
    Bjerkenstedt L; Gullberg B; Härnryd C; Sedvall G
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):107-18. PubMed ID: 21644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug.
    Refsum H; Amlie JP; Platou ES; Owren T; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):131-6. PubMed ID: 6114796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey.
    Hefner G; Unterecker S; Shams ME; Wolf M; Falter T; Haen E; Hiemke C
    J Neural Transm (Vienna); 2015 Nov; 122(11):1609-17. PubMed ID: 25940834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insight in persons with schizophrenia: effects of switching from conventional neuroleptics to atypical antipsychotics.
    Aguglia E; De Vanna M; Onor ML; Ferrara D
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1229-33. PubMed ID: 12502008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical experience with clozapine in 55 cases of treatment-resistant schizophrenia].
    Enomoto T; Ito T; Sekine K; Yasui R; Ashizawa Y; Uju Y; Hayakawa T; Tsukada K
    Seishin Shinkeigaku Zasshi; 2013; 115(9):953-66. PubMed ID: 24228473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET.
    Wiesel FA; Farde L; Halldin C
    Acta Psychiatr Scand Suppl; 1989; 352():30-4. PubMed ID: 2573239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
    Taylor DM; Young C; Paton C
    J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clozapine and negative symptoms. An open study.
    Llorca PM; Lancon C; Farisse J; Scotto JC
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Apr; 24(3):373-84. PubMed ID: 10836486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
    Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
    J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of serotonin in the action of atypical antipsychotic drugs.
    Meltzer HY
    Clin Neurosci; 1995; 3(2):64-75. PubMed ID: 7583621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.